Somatic hypermutation patterns in germinal center B cell malignancies

Hematology

Volumn 8, Issue 5, 2003, Pages 319-328

  Stamatopoulos, Kostas ^a   Belessi, Chrysoula ^b   Papadaki, Theodora ^c   Stavroyianni, Niki ^a   Hadzidimitriou, Anastasia ^a   Kosmas, Christos ^d   Laoutaris, Nikolaos ^b   Fassas, Athanasios ^a   Anagnostopoulos, Achilles ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b GENERAL HOSPITAL OF NIKEA   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d METAXA CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CYTIDINE DEAMINASE; DNA; FAS ANTIGEN; IMMUNOGLOBULIN; MYC PROTEIN; TUMOR SUPPRESSOR PROTEIN;

B CELL LYMPHOMA; B LYMPHOCYTE; DNA CLEAVAGE; FOLLICULAR LYMPHOMA; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; ONTOGENY; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SOMATIC HYPERMUTATION;

EID: 0142211188     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330310001612143     Document Type: Review

References (94)

1. Grawunder, U., West, R. and Lieber, M. (1998) "Antigen receptor gene rearrangement", Curr. Opin. Immunol. 10, 172-180.
2. Defrance, T., Casamayor-Palleja, M. and Krammer, P.H. (2002) "The life and death of a B cell", Adv. Cancer Res. 86, 195-225.
3. Guzman-Rojas, L., Sims-Mourtada, J.C., Rangel, R. and Martinez-Valdez, H. (2002) "Life and death within germinal centres: a double-edged sword", Immunology 107, 167-175.
4. Jacobs, H. and Bross, L. (2001) "Towards an understanding of somatic hypermutation", Curr. Opin. Immunol. 13, 208-218.
5. Manis, J.P., Tian, M. and Alt, F.W. (2002) "Mechanism and control of class-switch recombination", Trends Immunol. 23, 31-39.
6. Stevenson, F.K., Sahota, S.S., Ottensmeier, C.H., Zhu, D., Forconi, F. and Hamblin, T.J. (2001) "The occurrence and significance of V gene mutations in B cell-derived human malignancy", Adv. Cancer Res. 83, 81-116.
7. Foster, S.J., Dorner, T. and Lipsky, P.E. (1999) "Targeting and subsequent selection of somatic hypermutations in the human V kappa repertoire", Eur. J. Immunol. 29, 3122-3132.
8. Michael, N., Martin, T.E., Nicolae, D., Kim, N., Padjen, K., Zhan, P., Nguyen, H., Pinkert, C. and Storb, U. (2002) "Effects of sequence and structure on the hypermutability of immunoglobulin genes", Immunity 16, 123-134.
9. Shapiro, G.S. and Wysocki, L.J. (2002) "DNA target motifs of somatic mutagenesis in antibody genes", Crit. Rev. Immunol. 22, 183-200.
10. Sale, J.E., Bemark, M., Williams, G.T., Jolly, C.J., Ehrenstein, M.R., Rada, C., Milstein, C. and Neuberger, M.S. (2001) "In vivo and in vitro studies of immunoglobulin gene somatic hypermutation", Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 21-28.
11. Reynaud, C.A., Aoufouchi, S., Faili, A. and Weill, J.C. (2003) "What role for AID: mutator, or assembler of the immunoglobulin mutasome?", Nat. Immunol. 4, 631-638.
12. Okazaki, I., Yoshikawa, K., Kinoshita, K., Muramatsu, M., Nagaoka, H. and Honjo, T. (2003) "Activation-induced cytidine deaminase links class switch recombination and somatic hypermutation", Ann. N. Y. Acad. Sci. 987, 1-8.
13. Ramiro, A.R., Stavropoulos, P., Jankovic, M. and Nussenzweig, M.C. (2003) "Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand", Nat. Immunol. 4, 452-456.
14. Dickerson, S.K., Market, E., Besmer, E. and Papavasiliou, F.N. (2003) "AID mediates hypermutation by deaminating single stranded DNA", J. Exp. Med. 197, 1291-1296.
15. Papavasiliou, F.N. and Schatz, D.G. (2002) "Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity", Cell 109(Suppl.), 35-44.
16. Bross, L., Muramatsu, M., Kinoshita, K., Honjo, T. and Jacobs, H. (2002) "DNA double-strand breaks: prior to but not sufficient in targeting hypermutation", J. Exp. Med. 195, 1187-1192.
17. Jacobs, H., Rajewsky, K., Fukita, Y. and Bross, L. (2001) "Indirect and direct evidence for DNA double-strand breaks in hypermutating immunoglobulin genes", Philos Trans. R. Soc. Lond. B. Biol. Sci. 356, 119-125.
18. Goodman, M.F. (2002) "Error-prone repair DNA polymerases in prokaryotes and eukaryotes", Annu. Rev. Biochem. 71, 17-50.
19. Friedberg, E.C., Wagner, R. and Radman, M. (2002) "Specialized DNA polymerases, cellular survival, and the genesis of mutations", Science 296, 1627-1630.
20. Dunn-Walters, D., Thiede, C., Alpen, B. and Spencer, J. (2001) "Somatic hypermutation and B-cell lymphoma", Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 73-82.
21. Kuppers, R. and Dalla-Favera, R. (2001) "Mechanisms of chromosomal translocations in B cell lymphomas", Oncogene 20, 5580-5594.
22. Meijerink, J.P. (1997) "t(14;18), a journey to eternity", Leukemia 11, 2175-2187.
23. McDonnell, T.J. and Korsmeyer, S.J. (1991) "Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)", Nature 349, 254-256.
24. Janz, S., Potter, M. and Rabkin, C.S. (2003) "Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals", Genes Chromosomes Cancer 36, 211-223.
25. Stamatopoulos, K., Kosmas, C., Papadaki, T., Pouliou, E., Belessi, C., Afendaki, S., Anagnostou, D. and Loukopoulos, D. (1997) "Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains", Br. J. Haematol. 96, 132-146.
26. Noppe, S.M., Heirman, C., Bakkus, M.H., Brissinck, J., Schots, R. and Thielemans, K. (1999) "The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism", Br. J. Haematol. 107, 625-640.
27. Aarts, W.M., Bende, R.J., Steenbergen, E.J., Kluin, P.M., Ooms, E.C., Pals, S.T. and van Noesel, C.J. (2000) "Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load", Blood 95, 2922-2929.
28. Kosmas, C., Stamatopoulos, K., Papadaki, T., Belessi, C., Yataganas, X., Anagnostou, D. and Loukopoulos, D. (1998) "Somatic hypermutation of immunoglobulin variable region genes: focus on follicular lymphoma and multiple myeloma", Immunol. Rev. 162, 281-292.
29. Foster, S.J., Brezinschek, H.P., Brezinschek, R.I. and Lipsky, P.E. (1997) "Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM + B cells", J. Clin. Invest. 99, 1614-1627.
30. Chang, B. and Casali, P. (1994) "The CDR1 sequences of a major proportion of human germline IgVH genes are inherently susceptible to amino acid replacement", Immunol. Today 15, 367-373.
31. Dorner, T., Foster, S.J., Brezinschek, H.P. and Lipsky, P.E. (1998) "Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements", Immunol. Rev. 162, 161-171.
32. Wiens, G.D., Roberts, V.A., Whitcomb, E.A., O'Hare, T., Stenzel-Poore, M.P. and Rittenberg, M.B. (1998) "Harmful somatic mutations: lessons from the dark side", Immunol. Rev. 162, 197-209.
33. Belessi, C., Stamatopoulos, K., Stavroyianni, N., Zoi, K., Papadaki, T. and Kosmas, C. (2001) "Somatic hypermutation targeting to intrinsic hotspots of immunoglobulin genes in follicular lymphoma and multiple myeloma", Leukemia 15, 1772-1778.
34. Milstein, C., Neuberger, M.S. and Staden, R. (1998) "Both DNA strands of antibody genes are hypermutation targets", Proc. Natl Acad. Sci. USA 95, 8791-8794.
35. Zelenetz, A.D., Chen, T.T. and Levy, R. (1992) "Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection", J. Exp. Med. 176, 1137-1148.
36. Ottensmeier, C.H., Thompsett, A.R., Zhu, D., Wilkins, B.S., Sweetenham, J.W. and Stevenson, F.K. (1998) "Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression", Blood 91, 4292-4299.
37. Stamatopoulos, K., Kosmas, C., Belessi, C., Stavroyianni, N., Kyriazopoulos, P. and Papadaki, T. (2000) "Molecular insights into the immunopathogenesis of follicular lymphoma", Immunol. Today 21, 298-305.
38. Dunn-Walters, D., Boursier, L. and Spencer, J. (2000) "Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions", Mol. Immunol. 37, 107-113.
39. Zhu, D., McCarthy, H., Ottensmeier, C.H., Johnson, P., Hamblin, T.J. and Stevenson, F.K. (2002) "Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma", Blood 99, 2562-2568.
40. Sahota, S.S., Leo, R., Hamblin, T.J., Stevenson, F.K. and Myeloma, V.L. (1997) "VH gene sequences reveal a complementary imprint of antigen selection in tumor cells", Blood 89, 219-226.
41. Pileri, S.A., Ascani, S., Leoncini, L., Sabattini, E., Zinzani, P.L., Piccaluga, P.P., Pileri, A., Jr, Giunti, M., Falini, B., Bolis, G.B. and Stein, H. (2002) "Hodgkin's lymphoma: the pathologist's viewpoint", J. Clin. Pathol. 55, 162-176.
42. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. and Gatter, K.C. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361-1392.
43. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (1999) "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November, 1997", J. Clin. Oncol. 17, 3835-3849.
44. Anagnostopoulos, I., Hansmann, M.L., Franssila, K., Harris, M., Harris, N.L., Jaffe, E.S., Han, J., van Krieken, J.M., Poppema, S., Marafioti, T., Franklin, J., Sextro, M., Diehl, V. and Stein, H. (2000) "European task force on lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes", Blood 96, 1889-1899.
45. Jaffe, E.S., Harris, N.L., Vardiman, J. and Stein, H., eds (2001) Pathology and Genetics. Tumors of the Hematopoietic and Lymphoid Tissues. World Health Organization Classification of Malignant Tumors' (IARC Press, Lyon).
46. Kuppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R. and Hansmann, M.L. (1994) "Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development", Proc. Natl Acad. Sci. USA 91, 10962-10966.
47. Braeuninger, A., Kuppers, R., Strickler, J.G., Wacker, H.H., Rajewsky, K. and Hansmann, M.L. (1997) "Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells", Proc. Natl Acad. Sci. USA 94, 9337-9342.
48. Marafioti, T., Hummel, M., Anagnostopoulos, I., Foss, H.D., Falini, B., Delsol, G., Isaacson, P.G., Pileri, S. and Stein, H. (1997) "Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells", N. Engl. J. Med. 337, 453-458.
49. Muschen, M., Rajewsky, K., Brauninger, A., Baur, A.S., Oudejans, J.J., Roers, A., Hansmann, M.L. and Kuppers, R. (2000) "Rare occurrence of classical Hodgkin's disease as a T cell lymphoma", J. Exp. Med. 191, 387-394.
50. Kanzler, H., Kuppers, R., Hansmann, M.L. and Rajewsky, K. (1996) "Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled germinal center B cells", J. Exp. Med. 184, 1495-1505.
51. Marafioti, T., Hummel, M., Foss, H.D., Laumen, H., Korbjuhn, P., Anagnostopoulos, I., Lammert, H., Demel, G., Theil, J., Wirth, T. and Stein, H. (2000) "Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription", Blood 95, 1443-1450.
52. Jundt, F., Kley, K., Anagnostopoulos, I., Schulze Probsting, K., Greiner, A., Mathas, S., Scheidereit, C., Wirth, T., Stein, H. and Dorken, B. (2002) "Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease", Blood 99, 3060-3062.
53. Hertel, C.B., Zhou, X.G., Hamilton-Dutoit, S.J. and Junker, S. (2002) "Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma", Oncogene 21, 4908-4920.
54. Jundt, F., Anagnostopoulos, I., Forster, R., Mathas, S., Stein, H. and Dorken, B. (2002) "Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma", Blood 99, 3398-3403.
55. Souabni, A., Cobaleda, C., Schebesta, M. and Busslinger, M. (2002) "Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1", Immunity 17, 781-793.
56. Portis, T. and Longnecker, R. (2003) "Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development", J. Virol. 77, 105-114.
57. Schebesta, M., Heavey, B. and Busslinger, M. (2002) "Transcriptional control of B-cell development", Curr. Opin. Immunol. 14, 216-223.
58. Kay, N.E., Hamblin, T.J., Jelinek, D.F., Dewald, G.W., Byrd, J.C., Farag, S., Lucas, M. and Lin, T. (2002) "Chronic lymphocytic leukemia", Hematology (Am. Soc. Hematol. Educ. Program) 193-213.
59. Aksentijevich, I. and Flinn, I.W. (2003) "Chronic lymphocytic leukemia: advances in biology and therapeutics", Curr. Opin. Oncol. 15, 16-22.
60. Chiorazzi, N. and Ferrarini, M. (2003) "B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor", Annu. Rev. Immunol. 21, 841-894.
61. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. and Lichter, P. (2000) "Genomic aberrations and survival in chronic lymphocytic leukemia", N. Engl. J. Med. 343, 1910-1916.
62. Stilgenbauer, S., Bullinger, L., Lichter, P. and Dohner, H. (2002) "Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course", Leukemia 16, 993-1007.
63. Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valetto, A., Allen, S.L., Schulman, P., Vinciguerra, V.P., Rai, K., Rassenti, L.Z., Kipps, T.J., Dighiero, G., Schroeder, H.W., Jr., Ferrarini, M. and Chiorazzi, N. (1998) "Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors", J. Clin. Invest. 102, 1515-1525.
64. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. and Chiorazzi, N. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood 94, 1840-1847.
65. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood 94, 1848-1854.
66. Dyer, M.J. and Oscier, D.G. (2002) "The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia", Leukemia 16, 973-984.
67. Hamblin, T. (2002) "Chronic lymphocytic leukaemia: one disease or two?", Ann. Hematol. 81, 299-303.
68. Hamblin, T.J., Orchard, J.A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K. and Oscier, D.G. (2002) "CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease", Blood 99, 1023-1029.
69. Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Dohner, H. and Stilgenbauer, S. (2002) "V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia", Blood 100, 1410-1416.
70. Tobin, G., Thunberg, U., Johnson, A., Thorn, I., Soderberg, O., Hultdin, M., Botling, J., Enblad, G., Sallstrom, J., Sundstrom, C., Roos, G. and Rosenquist, R. (2002) "Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia", Blood 99, 2262-2264.
71. Lanham, S., Hamblin, T., Oscier, D., Ibbotson, R., Stevenson, F. and Packham, G. (2003) "Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia", Blood 101, 1087-1093.
72. Klein, U., Tu, Y., Stolovitzky, G.A., Mattioli, M., Cattoretti, G., Husson, H., Freedman, A., Inghirami, G., Cro, L., Baldini, L., Neri, A., Califano, A. and Dalla-Favera, R. (2001) "Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells", J. Exp. Med. 194, 1625-1638.
73. Rosenwald, A. and Staudt, L.M. (2002) "Clinical translation of gene expression profiling in lymphomas and leukemias", Semin. Oncol. 29, 258-263.
74. Chen, L., Widhopf, G., Huynh, L., Rassenti, L., Rai, K.R., Weiss, A. and Kipps, T.J. (2002) "Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia", Blood 100, 4609-4614.
75. Wiestner, A., Rosenwald, A., Barry, T.S., Wright, G., Davis, R.E., Henrickson, S.E., Zhao, H., Ibbotson, R.E., Orchard, J.A., Davis, Z., Stetler-Stevenson, M., Raffeld, M., Arthur, D.C., Marti, G.E., Wilson, W.H., Hamblin, T.J., Oscier, D.G. and Staudt, L.M. (2003) "ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile", Blood 101, 4944-4951.
76. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guillermo, A., Campo, E. and Montserrat, E. (2003) "ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia", N. Engl. J. Med. 348, 1764-1775.
77. Gurrieri, C., McGuire, P., Zan, H., Yan, X.J., Cerutti, A., Albesiano, E., Allen, S.L., Vinciguerra, V., Rai, K.R., Ferrarini, M., Casali, P. and Chiorazzi, N. (2002) "Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification", J. Exp. Med. 196, 629-639.
78. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, J., Jr, Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Staudt, L.M., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature 403, 503-511.
79. Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Yang, L., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Powell, J., Duffey, P.L., Longo, D.L., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Montserrat, E., Lopez-Guillermo, A., Grogan, T.M., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. and Staudt, L.M. (2002) "The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma", N. Engl. J. Med. 346, 1937-1947.
80. Kuppers, R., Rajewsky, K. and Hansmann, M.L. (1997) "Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression", Eur. J. Immunol. 27, 1398-1405.
81. Lossos, I.S., Okada, C.Y., Tibshirani, R., Warnke, R., Vose, J.M., Greiner, T.C. and Levy, R. (2000) "Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas", Blood 95, 1797-1803.
82. Thompsett, A.R., Ellison, D.W., Stevenson, F.K. and Zhu, D. (1999) "V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity", Blood 94, 1738-1746.
83. Taniguchi, M., Oka, K., Hiasa, A., Yamaguchi, M., Ohno, T., Kita, K. and Shiku, H. (1998) "De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation", Blood 91, 1145-1151.
84. Katzenberger, T., Lohr, A., Schwarz, S., Dreyling, M., Schoof, J., Nickenig, C., Stilgenbauer, S., Kalla, J., Ott, M.M., Muller-Hermelink, H.K. and Ott, G. (2003) "Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell", Blood 101, 699-702.
85. Leithauser, F., Bauerle, M., Huynh, M.Q. and Moller, P. (2001) "Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma", Blood 98, 2762-2770.
86. Lossos, I.S., Alizadeh, A.A., Eisen, M.B., Chan, W.C., Brown, P.O., Botstein, D., Staudt, L.M. and Levy, R. (2000) "Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas", Proc. Natl Acad. Sci. USA 97, 10209-10213.
87. Peng, H.Z., Du, M.Q., Koulis, A., Aiello, A., Dogan, A., Pan, L.X. and Isaacson, P.G. (1999) "Nonimmunoglobulin gene hypermutation in germinal center B cells", Blood 93, 2167-2172.
88. Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B.H., Knowles, D.M., Offit, K., Chaganti, R.S. and Dalla-Favera, R. (1995) "Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma", Proc. Natl Acad. Sci. USA 92, 12520-12524.
89. Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A., Baldini, L., Chaganti, R.S., Klein, U., Kuppers, R., Rajewsky, K. and Dalla-Favera, R. (1998) "BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci", Proc. Natl Acad. Sci. USA 95, 11816-11821.
90. Pasqualucci, L., Migliazza, A., Basso, K., Houldsworth, J., Chaganti, R.S. and Dalla-Favera, R. (2003) "Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma", Blood 101, 2914-2923.
91. Hecht, J.L. and Aster, J.C. (2000) "Molecular biology of Burkitt's lymphoma", J. Clin. Oncol. 18, 3707-3721.
92. Vanasse, G.J., Concannon, P. and Willerford, D.M. (1999) "Regulated genomic instability and neoplasia in the lymphoid lineage", Blood 94, 3997-4010.
93. Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S., Kuppers, R. and Dalla-Favera, R. (2001) "Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas", Nature 412, 341-346.
94. Muschen, M., Rajewsky, K., Kronke, M. and Kuppers, R. (2002) "The origin of CD95-gene mutations in B-cell lymphoma", Trends Immunol. 23, 75-80.